ADAM32 Oncogene in Hepatoblastoma Is Regulated by IGF2BP2
Open Access
Abstract
Background/Objectives: The membrane protein a disintegrin and metalloproteases (ADAMs) are highly expressed in various human carcinomas and play an important role in cancer characteristics. And among these, ADAM32 is highly expressed in hepatoblastoma (HBL) and plays an important role in oncogenic properties. However, the regulatory mechanism has not been determined. Recently, it has been reported that some ADAMs are regulated by HIF, which is an important transcription factor in response to hypoxia. Therefore, we decided to study the regulatory mechanisms of ADAM32 under hypoxic conditions by using HBL, breast, and lung cancer cell lines. Methods/Results: When these cells were exposed to 1% O2 (hypoxia), it was found that the levels of ADAM32 increased at 48 h in HepG2, MCF7, and MDA-MB-231 but not in HUH-6 or lung cancer lines. However, the promoter activity of the ADAM32 gene in HepG2 remained unchanged under hypoxic conditions, suggesting that the level of ADAM32 in HBL is regulated by factors other than the promoter activity. From the microarray data, we found that the level of IGF2BP2, which is an m6A-related molecule, correlated with that of ADAM32, and these levels were decreased by HIF1A knockdown. And IGF2BP2 knockdown decreased the expression of ADAM32 and attenuated the increased expression of ADAM32 under hypoxic conditions. Conclusions: This study demonstrated that the oncogenic gene ADAM32 is regulated by IGF2BP2 and that IGF2BP2 could be a molecular target for HBL anticancer therapy.Keywords
Funding Information
- JSPS KAKENHI (JP17K16265, JP20K17554, 19ck0106332h0003)
- Japan Agency for Medical Research and Development (JP17K16265, JP20K17554, 19ck0106332h0003)
This publication has 40 references indexed in Scilit:
- The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemiaCancer Cell, 2022
- LEAD‐m6A‐seq for Locus‐Specific Detection of N6‐Methyladenosine and Quantification of Differential MethylationAngewandte Chemie International Edition, 2020
- The m6A‑methylase complex and mRNA exportBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2019
- An Elongation‐ and Ligation‐Based qPCR Amplification Method for the Radiolabeling‐Free Detection of Locus‐Specific N6‐Methyladenosine ModificationAngewandte Chemie International Edition, 2018
- Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantationPediatric Blood & Cancer, 2018
- Dynamic RNA Modifications in Gene Expression RegulationCell, 2017
- Modulating tumor hypoxia by nanomedicine for effective cancer therapyJournal of Cellular Physiology, 2017
- Hypoxic tumor microenvironment: Opportunities to develop targeted therapiesBiotechnology Advances, 2016
- The Krüppel-like zinc finger transcription factor, GLI-similar 1, is regulated by hypoxia-inducible factors via non-canonical mechanismsBiochemical and Biophysical Research Communications, 2013
- The hypoxia-inducible factors: key transcriptional regulators of hypoxic responsesCellular and Molecular Life Sciences, 2003